- Home
- HDSN vs PVLA Comparison
HDSN vs PVLA Comparison
Compare HDSN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDSN
- PVLA
- Stock Information
- Founded
- HDSN 1991
- PVLA 2015
- Country
- HDSN United States
- PVLA United States
- Employees
- HDSN N/A
- PVLA N/A
- Industry
- HDSN Industrial Specialties
- PVLA Biotechnology: Pharmaceutical Preparations
- Sector
- HDSN Consumer Discretionary
- PVLA Health Care
- Exchange
- HDSN Nasdaq
- PVLA Nasdaq
- Market Cap
- HDSN 291.8M
- PVLA 253.2M
- IPO Year
- HDSN 1994
- PVLA N/A
- Fundamental
- Price
- HDSN $7.74
- PVLA $22.30
- Analyst Decision
- HDSN Buy
- PVLA Strong Buy
- Analyst Count
- HDSN 4
- PVLA 7
- Target Price
- HDSN $7.44
- PVLA $46.29
- AVG Volume (30 Days)
- HDSN 386.0K
- PVLA 81.8K
- Earning Date
- HDSN 08-05-2025
- PVLA 08-15-2025
- Dividend Yield
- HDSN N/A
- PVLA N/A
- EPS Growth
- HDSN N/A
- PVLA N/A
- EPS
- HDSN 0.38
- PVLA N/A
- Revenue
- HDSN $227,211,000.00
- PVLA N/A
- Revenue This Year
- HDSN N/A
- PVLA N/A
- Revenue Next Year
- HDSN $9.83
- PVLA N/A
- P/E Ratio
- HDSN $20.36
- PVLA N/A
- Revenue Growth
- HDSN N/A
- PVLA N/A
- 52 Week Low
- HDSN $5.11
- PVLA $11.17
- 52 Week High
- HDSN $9.28
- PVLA $29.27
- Technical
- Relative Strength Index (RSI)
- HDSN 60.59
- PVLA N/A
- Support Level
- HDSN $7.62
- PVLA N/A
- Resistance Level
- HDSN $8.04
- PVLA N/A
- Average True Range (ATR)
- HDSN 0.23
- PVLA 0.00
- MACD
- HDSN 0.03
- PVLA 0.00
- Stochastic Oscillator
- HDSN 71.43
- PVLA 0.00
About HDSN Hudson Technologies Inc.
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.